Moonbase
← Back to Awards
F31NIH · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTNIH

Dissecting how gene regulatory redundancy ensures robustness of mammalian development

Alcantara, Joshua Andrei (Contact)·University of California-Irvine, CA·2025–2028·ACTIVE
Donate

INSTITUTION

University of California-Irvine, CA

PRINCIPAL INVESTIGATOR

Alcantara, Joshua Andrei (Contact)

FUNDING

$47K

YEAR

2025

MOONBASE SCORE

Still being scored

LOADING MOONBASE SCORE

Abstract

PROJECT SUMMMARY/ABSTRACT Transcriptional enhancers are non-coding DNA elements that control the expression of their target genes with spatiotemporal specificity. Transcription factors confer the specificity of enhancer function by recruiting core transcriptional machinery to the enhancer’s target promoter during gene activation. Altered enhancer function may yield a variety of pathologies, including congenital anomalies. However, even under adverse environmental and genetic conditions, most births occur without congenital anomalies, attesting to the resilience of developmental programs. This “developmental robustness” may rely on the fact that most genes expressed during development are controlled by multiple redundant enhancers with overlapping spatiotemporal activities, so-called shadow enhancers. However, despite the ubiquity of these shadow enhancers, we do not completely understand how they confer developmental robustness. Using a mouse model of limb morphogenesis and genetic engineering at the mouse Gli3 genomic locus, I generated preliminary data suggesting that shadow enhancers are activated by distinct transcription factor inputs, despite their apparent redundancy. This “separation of transcription factor inputs” may be significant to shadow enhancers’ roles in supporting developmental robustness. The primary objective of this proposal is to identify the distinct transcription factors driving each shadow enhancer (Aim1) and characterize how two distinct shadow enhancers organize in the three-dimensional space of the nucleus during gene activation (Aim2). To achieve Aim 1, I will perform a genomic footprinting technique to determine which transcription factor binding sites are occupied within each shadow enhancer during gene activation. This approach will be complemented with an in vivo enhancer-reporter assay to functionally test for the requirement of each binding site. To accomplish Aim 2, I will perform three-color DNA fluorescence in situ hybridization (DNA-FISH), which will allow me to measure the co-localization of two shadow enhancers and the Gli3 promoter under different genetic conditions. The proposed research will unveil the molecular and spatial mechanisms of gene regulatory redundancy during mammalian development. Providing his expertise in gene regulation, mouse transgenics, and developmental biology, Dr. Evgeny Kvon will serve as my sponsor during the fellowship period. With consultation from Dr. Kvon, I have developed a robust training plan to facilitate my transition to becoming an independent investigator and biology educator. Under this proposal, I will learn new skills in genomics, DNA-FISH, transgenics, and bioinformatic analysis. My professional development will encompass training in scientific communication, teaching, and mentorship.

F31EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTSpecial Emphasis Panel[ZRG1 F08-L (20)]dimensionalprofessionalvarietyexpressedseparationtargetredundantpathologieshybridizationfactorenhancerstranscriptionalactivitiesgeneticduringunderdetermineconditionswithout

Are you the primary organization running this research?

The two tools below are built for the principal investigator & host institution behind this project.